Ueshima K, Oba K, Yasuno S, Fujimoto A, Tanaka S, Ogihara T, Saruta T, Nakao K. Influence of coronary risk factors on coronary events in Japanese high-risk hypertensive patients: primary and secondary prevention of ischemic heart disease in a subanalysis of the CASE-J (Candesartan Antihypertensive Survival Evaluation in Japan) trial. Circ J 2011; 75: 2411-6.
Nishimura R, Nakamura S, Oba K, Komoike Y, Mitsuyama S, Hisamatsu K, Oriuchi N, Abe C, Kuwayama T, Taguchi T, Sakamoto J, Noguchi S. Prospective study on the effect of toremifene in patients with adjuvant anastrozole failure in postmenopausal breast cancer. Ann Cancer Res Ther 2011; 1: 9-14.
Hara T, Nishikawa K, Sakatoku M, Oba K, Sakamoto J, Omura K. Phase II study of weekly paclitaxel, cisplatin and 5-fluorouracil for advanced gastric cancer. Gastric Cancer 2011; 14: 332-8.
Okuyama Y, Hazama S, Nozawa H, Kobayashi M, Takahashi K, Fujikawa K, Kato T, Nagata N, Kimura H, Oba K, Sakamoto J, Mishima H. Prospective Phase II Study of FOLFIRI for mCRC in Japan, Including the Analysis of UGT1A1*28/*6 Polymorphisms. Jpn J Clin Oncol 2011;41: 477-82.
Imamoto H, Oba K, Sakamoto J, Iishi H, Narahara H, Yumiba T, Morimoto T, Nakamura M, Oriuchi N, Kakutani C, Morita S, Shiozaki H. Assessing Clinical Benefit Response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer. Gastric Cancer 2011; 14: 81-90.
Oba K, Matsuoka M, Satoh T, Muro K, Oriuchi N, Sakamoto J, Mishima H. Multicentre Phase II Study of XELOX with Bevacizumab in Late-stage Elderly Patients with Unresectable Advanced/Recurrent Colorectal Cancer: An ASCA Study. Jpn J Clin Oncol 2011; 41: 134-8.
Krotov NF, Rasulov AE, Almardonov RB, Madiyarov BT, Chernishova TB, Oba K, Mamarajabov SE. Antireflux cervical esophagogastricoanastomosis in the surgery of esophageal cancer. Ann Cancer Res Ther 2010; 18: 59-64.
Ueshima K, Yasuno S, Oba K, Fujimoto A, Mukoyama M, Ogihara T, Saruta T, Nakao K. Impact of Left Ventricular Hypertrophy on the Time-course of Renal Function in Hypertensive Patients: A Subanalysis of the CASE-J Trial. Circ J 2010; 74: 2132-8.
Zamani S, Farnia M, Torknejad A, Alaei BA, Gholizadeh M, Kasraee F, Kihara MO, Oba K, Kihara M. Patterns of drug use and HIV-related risk behaviors among incarcerated people in a prison in Iran. J Urban Health 2010; 87: 603-16.
Yasuno S, Oba K, Ueshima K, Fujimoto A, Hirata M, Ogihara T, Saruta T, Nakao K. Is pulse pressure a predictor of new-onset diabetes in high-risk hypertensive patients? : A subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial. Diabetes Care 2010; 33: 1122-7.
Nakao K, Hirata M, Oba K, Yasuno S, Ueshima K, Fujimoto A, Ogihara T, Saruta T. Role of diabetes and obesity on outcomes of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial. Hypertens Res 2010; 33:600-6.